86 results on '"Cautela, Jennifer"'
Search Results
2. Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
3. Cardiovascular outcomes in patients with cancer during a 5-year follow-up: Results from a French administrative database
4. What Is the Evidence of the Diagnostic Criteria and Screening of Immune Checkpoint Inhibitor–Induced Myocarditis?
5. Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry
6. Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis
7. Device-Related Thrombus After Left Atrial Appendage Occlusion With the Amulet Device
8. La myocardite : une toxicité rare mais grave sous immunothérapie
9. Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients
10. Mechanical characterisation of human ascending aorta dissection
11. Dynamic iron status after acute heart failure
12. Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis
13. Ventricular Arrhythmia Occurrence and Compliance in Patients Treated With the Wearable Cardioverter Defibrillator Following Percutaneous Coronary Intervention
14. Impact of the time-to-treatment concept on the outcome of acute heart failure: A pilot study
15. Prevalence and characteristics of coronary artery disease in heart failure with preserved and mid-range ejection fractions: A systematic angiography approach
16. Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey
17. Prehospital and in-hospital course of care for patients with acute heart failure: Features and impact on prognosis in “real life”
18. Left Ventricular Longitudinal Strain Abnormalities in Childhood Exposure to Anthracycline Chemotherapy.
19. Uric acid levels are associated with endothelial dysfunction and severity of coronary atherosclerosis during a first episode of acute coronary syndrome
20. Management and research in cancer treatment-related cardiovascular toxicity: Challenges and perspectives
21. Simultaneous pulmonary vein cryoablation and cavotricuspid isthmus radiofrequency ablation in patients with combined atrial fibrillation and typical atrial flutter
22. Controlled sedation with midazolam and analgesia with nalbuphine to alleviate pain in patients undergoing subcutaneous implantable cardioverter defibrillator implantation
23. Infective Endocarditis: Prevention, Diagnosis, and Management
24. Overcoming challenges of immune checkpoint inhibitor-induced myocarditis diagnosis.
25. Effectiveness of Simulation-Based Training on Transesophageal Echocardiography Learning: The SIMULATOR Randomized Clinical Trial.
26. Analysis of cardiac dysfunction in a preclinical murine model of immune-mediated cardiotoxicity.
27. Immune Checkpoint Inhibitor-Induced Myositis/Myocarditis with Myasthenia Gravis-like Misleading Presentation: A Case Series in Intensive Care Unit.
28. Etiology of Pericarditis in a Prospective Cohort of 1162 Cases
29. Diagnostic yield of FDG positron-emission tomography/computed tomography in patients with CEID infection: a pilot study
30. Diagnosis of BCC by multiphoton laser tomography
31. Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis.
32. Diagnostic Value of the International Society of Cardio-Oncology Definition for Suspected Immune Checkpoint Inhibitor-Associated Myocarditis.
33. Cancer Therapies and Vascular Toxicities.
34. Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor–Associated Myocarditis: A Narrative Review.
35. Role of the NLRP3 inflammasome in myocarditis induced by immune checkpoint inhibitors cancer immunotherapy.
36. Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines.
37. Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients.
38. Immune Checkpoint Inhibitor Rechallenge After Immune-Related Adverse Events in Patients With Cancer.
39. High incidence of atrial fibrillation in patients treated with ibrutinib.
40. Identifying the factors that influence surgeon's compliance with excisional margins of non-melanoma skin cancer.
41. Takotsubo-Like Syndrome in Cancer Patients Treated With Immune Checkpoint Inhibitors.
42. Multiphoton Laser Microscopy and Fluorescence Lifetime Imaging for the Evaluation of the Skin
43. Cardiotoxicity is mediated by the NLRP3 inflammasome in hiPSC-derived endothelial cells from patients with immune checkpoint inhibitor-related myocarditis.
44. Pleiotropic effects of ticagrelor: Myth or reality?
45. Physical activity reduces longitudinal strain alteration in children treated by anthracyclins.
46. Immunotherapy-related cardiovascular toxicity: Development of a preclinical murine model of acute myocarditis.
47. Characterization of the inflammasome IFN-dependent in hiPSC-derived endothelial cells from ICIs-induced myocarditis patients.
48. Plaidoyer pour le dépistage échographique systématique précoce des toxicités cardiovasculaires post-traitement par cyclophosphamide-doxorubicine-vincristine-prednisone avec ou sans rituximab.
49. All rise! Orthostatic hypotension in heart failure: reply.
50. Potential of Oncocardiology.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.